Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | COVID-19 in Wisconsin, USA

Nirav Niranjan Shah • 18 May 2020
ASCO 2020

Nirav Niranjan Shah, MD, of the Medical College of Wisconsin, Milwaukee, WI, outlines changes in the treatment and management of patients as a result of COVID-19. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nirav Niranjan Shah

2:42
Dual-targeted anti-CD19/anti-CD20 CAR T-cells in R/R MCL: insights from a Phase I/II trial
Nirav Niranjan Shah • 11 Dec 2023
1:35
Pirtobrutinib in R/R FL: results from the BRUIN study
Nirav Niranjan Shah • 11 Dec 2023
Novel therapies in NHL: BTK inhibitors & degraders
Nirav Niranjan Shah et al. • 17 Oct 2023
2:13
Phase II trial of split-dose R-CHOP for older patients with DLBCL
Nirav Niranjan Shah • 4 Jun 2023
The content of VJHemOnc is intended for healthcare professionals